Spider Versus Emboshield Distal Protection on Cerebral Microembolization During Vulnerable Plaque in Carotid Artery Stenting
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 172 participants.
Also called NCT04904250
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 172 participants
- Sponsor
- Registry
-
NCT04904250
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04904250. Randomized; single masking; primary purpose treatment. Start 2022-08-27 (anticipated); primary completion 2024-05-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Spider Versus Emboshield Distal Protection on Cerebral Microembolization During Vulnerable Plaque in Carotid Artery Stenting
- Acronym
- CASH-ES
- Condition
- Stroke
- Condition
- Carotid Stenosis
- Condition
- Carotid Artery Stent
- Intervention (Device)
- Emboshield
- Intervention (Device)
- Spider
- Lead sponsor
- Xuanwu Hospital, Beijing
Record details
- Record id
cardio:ct-nct04904250- Content hash
62bd774c7ffcfdd7f1d8f2c48b5e1598f3c4f25cb20506ad825bdae3545becb2